Yeah... I am not a big conspiracy theory guy like you
Yeah... I am not a big conspiracy theory guy like you guys. I want to believe the world needs a drug or vaccine and the FDA will get us there as soon as possible. I can see that trials are set up easier for some than others but the finish line is in sight for Leronlimab in my eyes. Its just a matter of time and we will get there. If we have to do a phase 3 for CD-10 and even finish the CD-12. We will get there. I would like to not have to continue the Covid trials and hope for quick approval on great data. If the data doesn't show strong then we need more data it would seem.
If you believe in the intentional slowing of our trial then you must be excited at the prospect of the UK and European countries now being asked to acknowledge our current trials and our data to seek approval for not only Covid but HIV duel therapy in their countries This is the leverage that levels the playing field with another countries possible approval. Having Leronlimab approved in another country first will not bode well for the FDA. I thought we would get that leverage from Mexico but that didn't work out. Maybe now Mexico will also accept our data from our trial? Either way someone will approve our Covid BLA or the like.
Then the proverbial ace will be up Nader's sleeve when he is in the type A meeting.The pressure will be on the FDA to be fair and to perform to the level they need to. The uproar of the investors of CYDY alone will go viral if we are delayed with great or excellent data. Its a great thing that we get the data first and that we will be releasing it to main stream media first before the FDA. Hopefully that creates the positive storm we need before the FDA even receives the data. Then the magnifying glass will be on them to do the right thing for humanity.
Good luck to all of us and to the world. Leronlimab and other therapeutics are needed NOW. The chance that a vaccine doesn't work is pretty high from the doctors I have listened to. Therapeutics may be the only treatment for a few years if not forever. A vaccine may never work.
8
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...
Continue Reading
An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...
Continue Reading
Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...
Continue Reading
AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...
Continue Reading
Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...
Continue Reading
Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...
Continue Reading
Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...
Continue Reading
Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...
Continue Reading
A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...
Continue Reading
Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...
Continue Reading
Top 5 Most Recently Viewed Articles
A New Chapter for Canada's Oil Ambitions There's a fresh breeze blowing through the Canadian oil fields, and it feels like the makings of a new era. That's right—this new memorandum of understanding (MOU) might just be the kind of thing to finally nudge Canada closer to its dream of becoming a heavyweight in the global energy arena. In an age where everyone and their...
Continue Reading
Introducing AEON: A Revolutionary Humanoid Robot Hexagon has unveiled a groundbreaking humanoid robot named AEON, aimed at addressing pressing labor shortages across various industries. With advancements in measurement technologies, artificial intelligence, and autonomous systems, AEON is set to transform the landscape of robotics, making it pivotal in the pursuit of...
Continue Reading
GovCIO Enhances Federal Operations with Advanced XR Technology GovCIO, a leader in technology solutions for the federal government, is pioneering the adoption of Extended Reality (XR) to modernize training and improve operational efficiency. Their commitment to delivering state-of-the-art augmented and virtual reality (AR/VR) training systems empowers personnel to...
Continue Reading
Getty Images and Shutterstock Join Forces Getty Images Holdings, Inc. (GETY) and Shutterstock, Inc. (SSTK) are set to revolutionize the visual content landscape through a strategic merger. This merger aims to create a robust entity that will significantly impact the content market. Both companies' shares saw considerable gains in premarket trading when the announcement...
Continue Reading
AB Artea Bankas Notes Now Trading on Euronext Dublin AB Artea Bankas, a significant player in the financial services sector, has announced the successful admission of its senior preferred notes to Euronext Dublin. This strategic move opens avenues for investors and enhances the bank's presence in the capital markets. Details of the Admission On a significant day, the...
Continue Reading